Related Experiment Video

Updated: Jul 14, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids

Ya-Jen Chang1, Jing-Rong Huang, Yi-Chien Tsai

  • 1Genomics Research Center, Academia Sinica, Taipei 115, Taiwan.

Proceedings of the National Academy of Sciences of the United States of America
|June 15, 2007
PubMed

Insights

New alpha-galactosylceramide (alpha-GalCer) analogs enhance natural killer T (NKT) cell activation and Th1-biased immunity, demonstrating superior anticancer efficacy compared to alpha-GalCer in preclinical models.

Area of Science:

  • Immunology
  • Oncology
  • Glycolipid Chemistry

Background:

  • Alpha-galactosylceramide (alpha-GalCer) stimulates natural killer T (NKT) cells but has shown limited success in clinical trials for cancer treatment.
  • NKT cells play a crucial role in immune responses, producing both T helper (Th)1 and Th2 cytokines.

Purpose of the Study:

  • To evaluate novel alpha-galactosylceramide (alpha-GalCer) analogs for their ability to activate NKT cells via CD1-mediated T cell receptor (TCR) signaling.
  • To assess the anticancer efficacy of these alpha-GalCer analogs in preclinical cancer models.

Main Methods:

  • Synthesized and tested 16 alpha-GalCer analogs for in vitro NKT cell activation, cytokine production, and dendritic cell maturation.
  • Analyzed TCR signaling pathways, including CD3epsilon, ERK1/2, and CREB phosphorylation.
  • Evaluated in vivo anticancer efficacy in mouse models of breast and lung cancer.

Main Results:

  • Glycolipids with aromatic rings in their acyl or sphingosine tails showed enhanced Th1 cytokine induction, TCR activation, and NKT cell expansion compared to alpha-GalCer.
  • Specific analogs promoted Th1-biased immune responses and significantly improved anticancer potency in vivo.
  • Antigen-presenting cells enhanced NKT cell activation by glycolipids more effectively than non-antigen-presenting cells.

Conclusions:

  • Alpha-galactosylceramide analogs can be rationally designed to promote Th1-biased immunity.
  • These optimized analogs exhibit greater anticancer efficacy and immune-enhancing activities than the parent compound, alpha-GalCer.
  • Further development of these analogs holds promise for cancer immunotherapy.

More Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells13:18

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...